Rafina Innovations Inc. (VICA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | - USD | 100.0% |
| 2021 | -856.13 Thousand USD | -6112.92% |
| 2020 | -13.77 Thousand USD | 98.81% |
| 2019 | -1.16 Million USD | 72.04% |
| 2018 | -5.76 Million USD | -49.12% |
| 2017 | -2.8 Million USD | -81.16% |
| 2016 | -1.53 Million USD | 78.67% |
| 2015 | -9 Million USD | -131.97% |
| 2014 | -18.83 Million USD | -132.27% |
| 2013 | -1.33 Million USD | -9719.88% |
| 2012 | -13.62 Thousand USD | 41.76% |
| 2011 | -23.39 Thousand USD | 33.86% |
| 2010 | -35.37 Thousand USD | -9.38% |
| 2009 | -32.33 Thousand USD | 78.72% |
| 2008 | -151.79 Thousand USD | -53.32% |
| 2007 | -99.15 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q1 | -1.00 USD | -0.0% |
| 2022 FY | - USD | 100.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q4 | -1.00 USD | 100.0% |
| 2021 FY | - USD | -6112.92% |
| 2021 Q2 | 14.68 Thousand USD | 102.95% |
| 2021 Q1 | -497.73 Thousand USD | 0.0% |
| 2021 Q3 | -373.08 Thousand USD | -2641.42% |
| 2020 FY | - USD | 98.81% |
| 2019 FY | - USD | 72.04% |
| 2019 Q1 | -603.56 Thousand USD | 76.9% |
| 2018 Q1 | -675.27 Thousand USD | 51.24% |
| 2018 FY | - USD | -49.12% |
| 2018 Q4 | -2.61 Million USD | -622.0% |
| 2018 Q3 | -361.96 Thousand USD | 28.26% |
| 2018 Q2 | -504.53 Thousand USD | 25.28% |
| 2017 Q4 | -1.38 Million USD | -241.31% |
| 2017 Q3 | -405.72 Thousand USD | -44.26% |
| 2017 Q1 | -714.29 Thousand USD | -95.03% |
| 2017 FY | - USD | -81.16% |
| 2017 Q2 | -281.25 Thousand USD | 60.63% |
| 2016 Q2 | -662.81 Thousand USD | 37.84% |
| 2016 Q3 | 557.47 Thousand USD | 184.11% |
| 2016 Q4 | -366.24 Thousand USD | -165.7% |
| 2016 FY | - USD | 78.67% |
| 2016 Q1 | -1.06 Million USD | -69.82% |
| 2015 Q2 | -5.44 Million USD | -814.23% |
| 2015 Q1 | -595.93 Thousand USD | 96.32% |
| 2015 Q4 | -627.92 Thousand USD | -16.76% |
| 2015 Q3 | -537.78 Thousand USD | 90.13% |
| 2015 FY | - USD | -131.97% |
| 2014 Q3 | -478.47 Thousand USD | 66.96% |
| 2014 FY | - USD | -132.27% |
| 2014 Q2 | -1.44 Million USD | -1550.27% |
| 2014 Q1 | -87.74 Thousand USD | 93.34% |
| 2014 Q4 | -16.2 Million USD | -3285.97% |
| 2013 FY | - USD | -9719.88% |
| 2013 Q4 | -1.31 Million USD | -24938.65% |
| 2013 Q3 | -5265.00 USD | 21.7% |
| 2013 Q2 | -6724.00 USD | 18.64% |
| 2013 Q1 | -8264.00 USD | -358.09% |
| 2012 Q4 | -1804.00 USD | 43.63% |
| 2012 FY | - USD | 41.76% |
| 2012 Q2 | -6208.00 USD | -157.06% |
| 2012 Q1 | -2415.00 USD | 78.45% |
| 2012 Q3 | -3200.00 USD | 48.45% |
| 2011 FY | - USD | 33.86% |
| 2011 Q2 | -3355.00 USD | 3.59% |
| 2011 Q1 | -3480.00 USD | 80.09% |
| 2011 Q3 | -5355.00 USD | -59.61% |
| 2011 Q4 | -11.2 Thousand USD | -109.3% |
| 2010 Q1 | -8947.00 USD | 34.07% |
| 2010 Q3 | -4660.00 USD | -8.52% |
| 2010 Q2 | -4294.00 USD | 52.01% |
| 2010 Q4 | -17.47 Thousand USD | -275.02% |
| 2010 FY | - USD | -9.38% |
| 2009 Q1 | -9540.00 USD | 73.98% |
| 2009 FY | - USD | 78.72% |
| 2009 Q4 | -13.57 Thousand USD | -209.82% |
| 2009 Q3 | -4380.00 USD | 9.75% |
| 2009 Q2 | -4853.00 USD | 49.13% |
| 2008 Q4 | -36.67 Thousand USD | 25.51% |
| 2008 FY | - USD | -53.32% |
| 2008 Q1 | -62.47 Thousand USD | -61.63% |
| 2008 Q2 | -3643.00 USD | 94.17% |
| 2008 Q3 | -49.23 Thousand USD | -1251.36% |
| 2007 Q2 | -38.3 Thousand USD | 0.0% |
| 2007 Q4 | -38.65 Thousand USD | -0.92% |
| 2007 Q3 | -38.3 Thousand USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | -274.29 Thousand USD | 100.0% |
| IR-Med Inc. | -4.89 Million USD | 100.0% |
| Polarean Imaging plc | -11.19 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 100.0% |
| Avitar, Inc. | -1.66 Million USD | 100.0% |
| AVITA Medical, Inc. | -39.56 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Zecotek Photonics Inc. | -3.44 Million USD | 100.0% |
| QHSLab, Inc. | -91.29 Thousand USD | 100.0% |
| Wellstar International, Inc. | -1.35 Million USD | 100.0% |
| Össur hf. | 137.38 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 100.0% |
| Escalon Medical Corp. | -58.46 Thousand USD | 100.0% |
| Aurora Spine Corporation | -454.37 Thousand USD | 100.0% |
| BrainsWay Ltd. | -2.31 Million USD | 100.0% |
| Lattice Biologics Ltd. | - USD | NaN% |
| NewCardio, Inc. | -9.37 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 100.0% |
| Vivos Inc. | -2.79 Million USD | 100.0% |
| MicroPort Scientific Corporation | -347.57 Million USD | 100.0% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -1.66 Million USD | 100.0% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | 100.0% |
| Nanomix Corporation | -8.13 Million USD | 100.0% |
| Theraclion SA | -2.05 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | 100.0% |
| Positron Corporation | -1.45 Million USD | 100.0% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 100.0% |
| Lombard Medical, Inc. | -28.06 Million USD | 100.0% |
| ALR Technologies Inc. | -6.4 Million USD | 100.0% |
| Stratec SE | 39.91 Million USD | 100.0% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 100.0% |
| Heart Tronics, Inc. | -14.85 Million USD | 100.0% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 100.0% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -68.55 USD | 100.0% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 100.0% |
| Ingen Technologies, Inc. | -8639.00 USD | 100.0% |
| Odyssey Group International, Inc. | -2.13 Million USD | 100.0% |
| United American Healthcare Corporation | -59 Thousand USD | 100.0% |
| ECGI Holdings, Inc. | -2.99 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | 100.0% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | 100.0% |
| Urologix, Inc. | -6.34 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | 100.0% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | 100.0% |
| SS Innovations International, Inc. | -20.37 Million USD | 100.0% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | 100.0% |
| Smith & Nephew plc | 1 Billion USD | 100.0% |
| NIOX Group Plc | 11.07 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.83 Million USD | 100.0% |
| Broncus Holding Corporation | -25.19 Million USD | 100.0% |
| Brain Scientific Inc. | -7.93 Million USD | 100.0% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 100.0% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | 100.0% |